Assessing adherence-based quality measures in epilepsy

International Journal for Quality in Health Care

Volumn 24, Issue 3, 2012, Pages 293-300

  Goodman, Michael J ^a   Durkin, Michael ^b   Forlenza, Jamie ^b   Ye, Xiangyang ^a   Brixner, Diana I ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Epilepsy; Measurement of quality; Quality indicators; Quality management; Quality of care

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; PHENYTOIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; DRUG SURVEILLANCE PROGRAM; EMERGENCY WARD; EPILEPSY; FALLING; FEMALE; HEAD INJURY; HEALTH CARE QUALITY; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; COHORT STUDIES; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; ODDS RATIO; PHENYTOIN; PIRACETAM; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861551480     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzs017     Document Type: Article

References (18)

1. Institute of Medicine (U.S.). Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, 2001.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K et al. How common are the 'common' neurologic disorders? Neurology 2007;68:326-37.
3. National Epilepsy Foundation. Epilepsy and seizure statistics. http://www.epilepsyfoundation.org/about/statistics.cfm.
4. Sander JW. The use of antiepileptic drugs-principles and practice. Epilepsia 2004;45(Suppl. 6):28-34.
5. Davis KL. Prevalence and cost impact of nonadherence with antiepilepsy drugs among adults in a managed care population. Academy of Managed Care Pharmacy 19th Annual Meeting Showcase. San Diego, CA, 2007.
6. Jones RM, Butler JA, Thomas VA et al. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006;15:504-8.
7. Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-42.
8. Manjunath R, Davis KL, Candrilli SD et al. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009;14:372-8.
9. Faught E, Duh MS, Weiner JR et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;71:1572-8.
10. Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008;49:446-54.
11. Hess LM, Raebel MA, Conner DA et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8.
12. Vanderpoel DR, Hussein MA, Watson-Heidari T et al. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clin Ther 2004;26:2066-75.
13. Ettinger AB, Manjunath R, Candrilli SD et al. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009;14:324-9.
14. Pharmacy Quality Alliance. PQA approved measures, 2010. http://www.pqaalliance.org/files/PQA%20approved%20 measures.pdf (1 November 2010, date last accessed).
15. Martin BC, Wiley-Exley EK, Richards S et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009;43:36-44.
16. Weiden PJ, Kozma C, Grogg A et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004;55:886-91.
17. Karve S, Cleves MA, Helm M et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008;46: 1125-33.
18. Vink NM, Klungel OH, Stolk RP et al. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf 2009;18: 159-65.